theheart.org: Cardiology news, educational programming, and opinions

Arrhythmia/EP

Reducing Atrial Fibrillation-Related Hospitalizations

Jul 2, 2009 09:30 EDT

AF is the leading cause of arrhythmia-related hospitalizations and affects nearly 7 million people in the United States and Europe. Please join Drs. Dorian, Curtis, and Hohnloser for a discussion on strategies to reduce hospitalization rates for patients with AF.

Arrhythmia/EP

Understanding Heart Failure and Atrial Fibrillation

Jul 2, 2009 09:30 EDT

AF is the most common sustained arrhythmia and significantly increases an individual's risk for heart failure. Join our expert panel: Drs. Naccarelli, Cannon, and Connolly for an in-depth discussion of new data and management strategies for improving outcomes in patients with AF.

Acute Coronary Syndromes

Antiplatelet Therapy: The Latin American Perspective

Jul 1, 2009 13:57 EDT

HORIZONS-AMI has influenced US practice; after TRITON-TIMI 38, the potential role of prasugrel is a hot topic. How has Latin America responded to these data? Recorded at SOLACI 2009, Dr. Mahmud has an information exchange on contemporary antiplatelet management with two of Argentina's leading interventionalists, Drs. Grinfeld and Londero.

Hypertension

Crossroads of Risk - Hypertension and Diabetes

Jun 29, 2009 10:07 EDT

Microalbuminuria does not only signal worsening renal function but is an important marker in cardiovascular risk assessment. Join our expert panel, Drs. Izzo, Ruilope, and Weir as they discuss the interplay of diabetes and hypertension on the cardiovascular risk continuum.

Interventional/Surgery

Transcatheter Aortic Valves: Lessons From Europe

Jun 26, 2009 00:02 EDT

Transcatheter aortic valve implantation (TAVI) has been approved in Europe since 2007, whereas these devices are just entering large-scale research trials in the United States. Dr. Popma leads a panel discussion with European interventionalist Dr. Eberhard Grube and surgeon Dr. Neil Moat on their experiences with TAVI.

Acute Coronary Syndromes

Managing ACS: Exploring Evolving Options for Antiplatelet and Anticoagulant Therapy

Jun 23, 2009 10:38 EDT

As innovative research expands and unfolds, management of the patient with acute coronary syndrome continually takes on new dimensions. Join Dr. Eugene Braunwald and other experts as they delve into current and future pharmacotherapeutic strategies and issues surrounding the best practices for ACS patients.

Clinical cardiology

New Data on Polyvascular Disease and ACS

Jun 23, 2009 09:40 EDT

Recently published data suggest that prior polyvascular disease increases the risk for inhospital adverse events in patients with ACS. Join Drs. Deepak Bhatt, Jean-Pierre Bassand, and José R. Gonzalez-Juanatey for a discussion of the current data on identification and management of patients with polyvascular disease.

Interventional/Surgery

DES and PCI: Endurance and New Frontiers

1 COMMENT - Jun 23, 2009 00:45 EDT

Given SYNTAX, is left main stenting ready for primetime? Do the NCDR data lay to rest DES safety concerns? Recorded at EuroPCR 2009, Dr. Popma discusses the current status and future roles of PCI and DES with Drs.Gershlick and Tamburino.

Interventional/Surgery

There's Triple Vessel Disease and Triple Vessel Disease: Risk Assessment

Jun 22, 2009 08:08 EDT

How do the results of the SYNTAX trial impact clinical practice now? Join Drs. Banning and Hill as they present a complex case taken directly from the SYNTAX trial and discuss how new data will impact their choice of treatment, and listen to an overview of the trial presented by Dr. William Wijns.

Hypertension

Obstacles to Gaining Control of Hypertension

Jun 19, 2009 00:00 EDT

Join Drs. Weber, Basile, and Gradman as they discuss methods of overcoming "clinical inertia" and strategies to ensure that more patients achieve their blood pressure goals.

Clinical cardiology

Combination Therapy and Cardiovascular Events: A Neurologist's Perspective

Jun 17, 2009 11:48 EDT

AF can lead to stroke, congestive heart failure, and other serious complications. Successful management should include reducing these risks. Join our expert panel, Drs. Peter Rothwell, Donald Easton, and Mark Alberts, as they discuss new data and strategies for improving outcomes in patients with AF.

Acute Coronary Syndromes

IIb or Not IIb: The Role of GP IIb/IIIa Inhibitors in ACS

Jun 15, 2009 13:47 EDT

After EARLY-ACS and HORIZONS-AMI, the utility of routine GP IIb/IIIa inhibitors in contemporary management of ACS patients has been challenged. Studies of prehospital and pre-angiography administration have yielded mixed results, largely reflecting different trial designs. Dr. Gershlick aims to clarify matters with Drs. Hamm and Mehran.

Clinical cardiology

2009 Antiplatelet Debate: What's New in ACS

1 COMMENT - Jun 12, 2009 15:03 EDT

Despite modern therapy, the rates of death, MI, bleeding, and readmission remain high in patients with ACS. Join Drs. Jeffery Popma, Héctor Bueno, Freek Verheugt, and Sunil. Rao for a review of the latest data on antiplatelet therapy for patients with ACS.

Acute Coronary Syndromes

iQandA Interactive Medical Intelligence Zone for Interventional Cardiology

Jun 5, 2009 09:56 EDT

iQandA, The Interactive Medical Intelligence Zone is a needs assessment-driven continuing medical education (CME) activity that utilizes international experts to provide evidence-based, guideline-consistent, and practice behavior-changing information focused on critical and challenging topics in clinical medicine.

Arrhythmia/EP

The Pros and Cons of Lead Extraction

May 29, 2009 00:44 EDT

Join two of the world's leading experts in implantable devices, Dr. Bruce L. Wilkoff and Dr. George H. Crossley, as they discuss key issues surrounding the pros and cons of lead extraction.

Foundational programs

All About Eve: The Unique Aspects of CVD in Women

May 29, 2009 00:00 EDT

We know there are sex and biological differences in the manifestation of CVD. How do these pathophysiological differences affect the diagnosis and treatment of our female patients? Drs. Hayes, Johnson, Manson, and Piña provide their insight.

Arrhythmia/EP

The Future of Ambulatory Monitoring: Moving Beyond Rate and Rhythm to Monitor ST-Segment Shifts

May 29, 2009 00:00 EDT

How can we reduce the time taken to accurately diagnose ACS? ECGs and biomarkers may be nondiagnostic, even the presenting symptoms can vary or be absent. As every 30 minutes delay is associated with a 7.5% relative increase in mortality, time is indeed muscle. Join Drs. Gibson, Pride, Santini, and Krucoff as they present new insights into this complex field.

Imaging

Imaging and Risk Stratification in Heart Failure: Practical Perspectives

May 28, 2009 00:00 EDT

Drs. Prystowsky and Buxton engage nuclear cardiologists, Drs. Udelson and Cerqueira, to define what EPs need to know about a new imaging risk stratification tool for HF

Clinical cardiology

Atherothrombosis and Bleeding Issues: Balancing Safety and Efficacy

May 14, 2009 08:34 EDT

Bleeding in ACS patients has been associated with increased adverse cardiac events and negative patient outcomes. Join Drs. Keith Fox, Greg Stone, and Gabriel Steg as they discuss balancing the safety and efficacy of antithrombotic treatment options in ACS.

Interventional/Surgery

Variable Rate Contrast Injection in the Cath Lab

6 COMMENTS - May 11, 2009 10:00 EDT

Variable rate contrast delivery systems have the potential to improve workflow and patient outcomes by providing a more precise flow of contrast. Watch Dr. Jeffrey Moses and his team as they demonstrate the use of the device in the cath lab in a patient with complex lesions.

Acute Coronary Syndromes

Antiplatelet Therapy in an ACS Patient With Diabetes

May 5, 2009 00:00 EDT

Patients with diabetes have more reactive platelets and are also more likely to have a diminished response to antiplatelet therapy. Dr. Angiolillo presents Dr. Storey with a case illustrating issues in the management of antiplatelet therapy in an ACS patient with diabetes.

Acute Coronary Syndromes

Upstream Adjunctive Therapy: The Importance of Early Timing in the Treatment of NSTEMI

3 COMMENTS - Apr 29, 2009 00:00 EDT

Join Drs. Harrington, Gibson, and Bates as they discuss the difficult issues of antithrombotic choices and the medical management of patients with NSTEMI.

Clinical cardiology

Preventing Vascular Events in AF: What Is the Role of Antiplatelet Therapy?

3 COMMENTS - Apr 28, 2009 10:00 EDT

Atrial fibrillation (AF) is the most frequently occurring cardiac arrhythmia affecting some 2.2 million Americans with often serious clinical consequences.. Join Drs. Bhatt, Connolly and Camm for a discussion on the risk factors, management challenges, and new data on treatment options for patients with AF

Hypertension

Analyzing the ACE/ARB Combo Concern

11 COMMENTS - Apr 24, 2009 00:00 EDT

Inhibiting the RAS: how much and for what indications? Is there consensus?

Imaging

Imaging of Heart Failure: Improving Prognosis and Management Decisions

1 COMMENT - Apr 24, 2009 00:00 EDT

Drs. Topol, Cerqueira, and Garcia react to the ADMIRE-HF trial data, which ushers in a new paradigm in HF risk stratification strategies.

	Yes
	No